Back to articles
Jesse Landry

Long Tail Secures Strategic Investment to Tackle Healthcare Denials

Denials don’t knock. They stack. Quietly at first, then all at once, until health systems are buried under decisions they didn’t really make. That pressure, that friction, that constant negotiation with payers is exactly where Long Tail chose to build from day 1 in 2023.

Fast forward to now, and Long Tail, the Chicago-based AI-native utilization management and physician advisory company, just locked in a strategic growth investment from Eir Partners Capital. No dollar signs flashing in neon, no vanity metrics. Just signal. And if you’ve been around this game long enough, you know that’s usually where the real story lives.

Jeff Means, CEO and Co-Founder, isn’t new to the revenue cycle trenches. This isn’t theory dressed up as product. This is lived experience, translated into software and services that go straight at utilization management, denials, and appeals workflows. The parts of healthcare where complexity isn’t a bug, it’s the business model. Long Tail leans into that chaos with proprietary payer intelligence and AI-driven automation, turning what used to be reactive into something a lot closer to controlled.

Eir Partners Capital stepping in here isn’t random. They’ve built their name backing healthcare tech that actually moves the needle, not just decorates it. Their bet signals that utilization management and physician advisory are no longer back-office conversations. They’re front-line strategy. When reimbursement pressure tightens, the winners are the ones who understand the rules nobody wrote down. That’s where Long Tail plays.

What stands out is how this came together. No hype cycle, no overextended narrative. A focused product, a clear problem, and a growing network feeding the kind of payer intelligence most systems wish they had 5 years ago. That combination travels. Especially in a market where hospitals and health systems are done guessing and ready to start seeing patterns before they become problems.

This capital is aimed at product innovation, expanding that data network, and scaling go-to-market. Translation: more signal, less noise, and a bigger footprint where it actually counts. The kind of move that doesn’t just support growth, it sharpens it.

Congratulations to Jeff Means and the Long Tail team, and to Eir Partners Capital for spotting the edge early. In a system full of friction, the companies that win are the ones that learn how to read between the denials.